Transcat, Inc. (NASDAQ:TRNS) Director John T. Smith sold 5,000 shares of Transcat stock in a transaction dated Thursday, June 6th. The stock was sold at an average price of $24.66, for a total value of $123,300.00. Following the completion of the transaction, the director now directly owns 30,555 shares of the company’s stock, valued at $753,486.30. The transaction was disclosed in a document filed with the SEC, which is available at this link.
Shares of Transcat stock opened at $24.64 on Thursday. Transcat, Inc. has a one year low of $17.30 and a one year high of $26.96. The stock has a market capitalization of $175.63 million, a P/E ratio of 25.94, a PEG ratio of 2.89 and a beta of 0.78. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.03 and a quick ratio of 1.45.
Transcat (NASDAQ:TRNS) last issued its earnings results on Tuesday, May 21st. The scientific and technical instruments company reported $0.35 EPS for the quarter, beating analysts’ consensus estimates of $0.26 by $0.09. Transcat had a return on equity of 12.77% and a net margin of 4.44%. The business had revenue of $44.49 million during the quarter, compared to analyst estimates of $41.90 million. Analysts expect that Transcat, Inc. will post 1.04 EPS for the current fiscal year.
A number of institutional investors have recently modified their holdings of the stock. Dalton Greiner Hartman Maher & Co. boosted its stake in Transcat by 8.4% during the 1st quarter. Dalton Greiner Hartman Maher & Co. now owns 249,323 shares of the scientific and technical instruments company’s stock valued at $5,729,000 after purchasing an additional 19,292 shares during the last quarter. Segall Bryant & Hamill LLC boosted its stake in Transcat by 29.4% during the 4th quarter. Segall Bryant & Hamill LLC now owns 29,569 shares of the scientific and technical instruments company’s stock valued at $562,000 after purchasing an additional 6,720 shares during the last quarter. Vanguard Group Inc. boosted its stake in Transcat by 1.6% during the 3rd quarter. Vanguard Group Inc. now owns 253,133 shares of the scientific and technical instruments company’s stock valued at $5,785,000 after purchasing an additional 3,945 shares during the last quarter. Tibra Equities Europe Ltd acquired a new position in Transcat during the 1st quarter valued at about $336,000. Finally, Quantum Capital Management boosted its stake in Transcat by 11.1% during the 4th quarter. Quantum Capital Management now owns 78,867 shares of the scientific and technical instruments company’s stock valued at $1,500,000 after purchasing an additional 7,868 shares during the last quarter. 62.06% of the stock is owned by institutional investors and hedge funds.
Separately, Zacks Investment Research raised Transcat from a “hold” rating to a “buy” rating and set a $28.00 target price for the company in a research report on Saturday, May 25th.
WARNING: “Transcat, Inc. (NASDAQ:TRNS) Director Sells $123,300.00 in Stock” was originally reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this piece of content on another domain, it was copied illegally and republished in violation of U.S. & international copyright laws. The legal version of this piece of content can be accessed at https://www.dispatchtribunal.com/2019/06/13/transcat-inc-nasdaqtrns-director-sells-123300-00-in-stock.html.
Transcat, Inc provides calibration and laboratory instrument services in North America and internationally. It operates in two segments, Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.
Featured Story: The Discount Rate – What You Need to Know
Receive News & Ratings for Transcat Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transcat and related companies with MarketBeat.com's FREE daily email newsletter.